Frederik E Stuurman (F E Stuurman, Rik F E Stuurman, Rik Stuurman)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Venues

Translational psychiatry

Drug delivery

PloS one

Journal of psychopharmacology (Oxford, England)

Centre for Human Drug Research

Utrecht University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centre for Human Drug Research

Netherlands

Senior clinical scientist :: clinical pharmacology

PRA Health Sciences Zuidlaren

Netherlands

Project manager :: clinical pharmacology

Antoni van Leeuwenhoek Nederlands Kanker Instituut

Netherlands

scientist :: clincial pharmacology

Schering-Plough

Netherlands

Trainee Pharmacist

Education History

Utrecht University Jan 01 2009 - Sep 18 2013

Netherlands

PHD :: Pharmacy

Rijksuniversiteit Groningen

Netherlands

MSC :: Pharmaceutical sciences

Rijksuniversiteit Groningen

Netherlands

MSC :: Pharmacy

Publications

Guilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, Wouter P C Boon, Huub Schellekens, Ellen H M Moors, Peter J K van Meer, Frederik E Stuurman, Joop M A van Gerven
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs. Translational psychiatry 13 (1) (2023)
Guilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, Wouter P C Boon, Huub Schellekens, Ellen H M Moors, Peter J K van Meer, Frederik E Stuurman, Joop M A van Gerven
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs. Translational psychiatry 13 (1) (2023)
Guilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, Wouter P C Boon, Huub Schellekens, Ellen H M Moors, Peter J K van Meer, Frederik E Stuurman, Joop M A van Gerven
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs. Translational psychiatry 13 (1) (2023)
Willem de Laat, Lisa Pagan, Robert Karl Malcolm, Maarten Wiegerinck, Victor Nickolson, Bertine W Huisman, Frederik E Stuurman, Michiel Joost van Esdonk, Naomi Klarenbeek
First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring. Drug delivery 30 (1) (2023)
Willem de Laat, Lisa Pagan, Robert Karl Malcolm, Maarten Wiegerinck, Victor Nickolson, Bertine W Huisman, Frederik E Stuurman, Michiel Joost van Esdonk, Naomi Klarenbeek
First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring. Drug delivery 30 (1) (2023)
Willem de Laat, Lisa Pagan, Robert Karl Malcolm, Maarten Wiegerinck, Victor Nickolson, Bertine W Huisman, Frederik E Stuurman, Michiel Joost van Esdonk, Naomi Klarenbeek
First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring. Drug delivery 30 (1) (2023)
Guilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, Wouter P C Boon, Huub Schellekens, Ellen H M Moors, Peter J K van Meer, Frederik E Stuurman, Joop M A van Gerven
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs. Translational psychiatry 13 (1) (2023)
Josephina P M Vrouwe, Ingrid M C Kamerling, Michiel Joost van Esdonk, Josbert M Metselaar, Frederik E Stuurman, Gabri van der Pluijm, Jacobus Burggraaf, Susanne Osanto
An exploratory first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2- and 1-week interval in patients with metastatic castration resistant prostate cancer. Pharmacology research & perspectives 9 (5) (2022)
Francis M Dijkstra, Aurora Jae van de Loo, Smedra Abdulahad, Else R Bosma, Mitch Hartog, Hendrikje Huls, Dianne C Kuijper, Esther de Vries, Bhavna Solanki, Jaskaran Singh, Leah Aluisio, Peter Zannikos, Frederik E Stuurman, Gabriël E Jacobs, Joris C Verster
The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder. Journal of psychopharmacology (Oxford, England) 36 (5) (2022)
Matthijs D Kruizinga, N van der Heide, A Moll, A Zhuparris, Y Yavuz, M L de Kam, Frederik E Stuurman, A F Cohen, G J A Driessen
Towards remote monitoring in pediatric care and clinical trials-Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity, heart rate and sleep in healthy children. PloS one 16 (1) (2021)
Amadou Samb, Matthijs D Kruizinga, Younes Tallahi, Michiel Joost van Esdonk, Willemijn van Heel, Gertjan Driessen, Yuma Bijleveld, Frederik E Stuurman, Adam A Cohen, Anton van Kaam, Timo R de Haan, Ron Mathôt
Saliva as a sampling matrix for therapeutic drug monitoring of gentamicin in neonates: A prospective population pharmacokinetic and simulation study. British journal of clinical pharmacology (2021)
Charlotte Bakker, Michiel J van Esdonk, Frederik E Stuurman, Laura G J M Borghans, Marieke L de Kam, Joop M A van Gerven, Geert Jan Groeneveld
Biperiden Challenge Model in Healthy Elderly as Proof-of-Pharmacology Tool: A Randomized, Placebo-Controlled Trial. Journal of clinical pharmacology 61 (11) (2021)
Vincent A de Weger, Frederik E Stuurman, Stijn L W Koolen, Johannes J Moes, Jeroen J M A Hendrikx, Emilia Sawicki, Bas Thijssen, Marianne Keessen, Hilde Rosing, Marja Mergui-Roelvink, Alwin D R Huitema, Bastiaan Nuijen, Jos H Beijnen, Jan H M Schellens, Serena Marchetti
A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (18) (2019)
Aliede E In 't Veld, Hendrika W Grievink, Mahdi Saghari, Frederik E Stuurman, Marieke L de Kam, Aiko P J de Vries, Brenda C M de Winter, Jacobus Burggraaf, Adam F Cohen, Matthijs Moerland
Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring? International journal of molecular sciences 20 (19) (2019)
Jules A A C Heuberger, Pim Gal, Frederik E Stuurman, Wouter A S de Muinck Keizer, Yuri Mejia Miranda, Adam F Cohen
Repeatability and predictive value of lactate threshold concepts in endurance sports. PloS one 13 (11) (2018)

Frederik E Stuurman.css-eqlu8i{font-size:small;padding-left:4px;} (F E Stuurman, Rik F E Stuurman, Rik Stuurman)

Publication Activity (10 Years)

Top Topics

Top Venues

Frederik E Stuurman (F E Stuurman, Rik F E Stuurman, Rik Stuurman)